These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38347793)

  • 1. Traditional Chinese Medicine-based Treatment in Cardiovascular Disease: Potential Mechanisms of Action.
    Li L; Ran Y; Wen J; Lu Y; Liu S; Li H; Cheng M
    Curr Pharm Biotechnol; 2024 Feb; ():. PubMed ID: 38347793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traditional Chinese medicine and mitophagy: A novel approach for cardiovascular disease management.
    Wang J; Zou J; Shi Y; Zeng N; Guo D; Wang H; Zhao C; Luan F; Zhang X; Sun J
    Phytomedicine; 2024 Jun; 128():155472. PubMed ID: 38461630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal mucosal barrier: a potential target for traditional Chinese medicine in the treatment of cardiovascular diseases.
    Liu J; Wei X; Wang T; Zhang M; Gao Y; Cheng Y; Chi L
    Front Pharmacol; 2024; 15():1372766. PubMed ID: 38469405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network pharmacology provides a systematic approach to understanding the treatment of ischemic heart diseases with traditional Chinese medicine.
    Yang HY; Liu ML; Luo P; Yao XS; Zhou H
    Phytomedicine; 2022 Sep; 104():154268. PubMed ID: 35777118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Precise application of Traditional Chinese Medicine in minimally-invasive techniques].
    Dong FH
    Zhongguo Gu Shang; 2018 Jun; 31(6):493-496. PubMed ID: 29945400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research progress on effects of traditional Chinese medicine on myocardial ischemia-reperfusion injury: A review.
    Xing N; Long XT; Zhang HJ; Fu LD; Huang JY; Chaurembo AI; Chanda F; Xu YJ; Shu C; Lin KX; Yang K; Lin HB
    Front Pharmacol; 2022; 13():1055248. PubMed ID: 36561346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research progress of natural medicine Astragalus mongholicus Bunge in treatment of myocardial fibrosis.
    Ren C; Zhao X; Liu K; Wang L; Chen Q; Jiang H; Gao X; Lv X; Zhi X; Wu X; Li Y
    J Ethnopharmacol; 2023 Apr; 305():116128. PubMed ID: 36623754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulation of myocardial ischemia reperfusion injury signal pathway by flavonoid monomer].
    Hu YQ; Liu JH
    Zhongguo Zhong Yao Za Zhi; 2023 Feb; 48(4):879-889. PubMed ID: 36872258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Interactions between Traditional Chinese Medicines and Cardiovascular Drugs.
    Shen Q; Chen W; Wang W; Kang S; Du Y; Shi J; Yao L; Li W
    Eur J Drug Metab Pharmacokinet; 2024 Sep; 49(5):559-582. PubMed ID: 39008006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic targets by traditional Chinese medicine for ischemia-reperfusion injury induced apoptosis on cardiovascular and cerebrovascular diseases.
    Cheng X; Hu J; Liu X; Tibenda JJ; Wang X; Zhao Q
    Front Pharmacol; 2022; 13():934256. PubMed ID: 36060007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Traditional Chinese medicine enhances myocardial metabolism during heart failure.
    Shao-Mei W; Li-Fang Y; Li-Hong W
    Biomed Pharmacother; 2022 Feb; 146():112538. PubMed ID: 34922111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles and mechanisms of puerarin on cardiovascular disease：A review.
    Jiang Z; Cui X; Qu P; Shang C; Xiang M; Wang J
    Biomed Pharmacother; 2022 Mar; 147():112655. PubMed ID: 35066299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between calcium overload and myocardial ischemia reperfusion injury and intervention strategy of Chinese herbal medicine].
    Li JP; Guo LL; Chen Z; Wang R; Wang J
    Zhongguo Zhong Yao Za Zhi; 2016 Jun; 41(11):2168-2173. PubMed ID: 28901117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease treatment using traditional Chinese medicine：Mitochondria as the Achilles' heel.
    Gao J; Hou T
    Biomed Pharmacother; 2023 Aug; 164():114999. PubMed ID: 37311280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Traditional Chinese Medicine on the Cardiovascular Diseases.
    Jiang Y; Zhao Q; Li L; Huang S; Yi S; Hu Z
    Front Pharmacol; 2022; 13():806300. PubMed ID: 35387325
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.
    Li H
    J Ethnopharmacol; 2020 Apr; 251():112442. PubMed ID: 31891799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: Pharmacology and mechanisms.
    Li X; Li L; Lei W; Chua HZ; Li Z; Huang X; Wang Q; Li N; Zhang H
    Biomed Pharmacother; 2021 Oct; 142():111979. PubMed ID: 34358754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Effects of Traditional Chinese Medicine on Cardiovascular Diseases: the Central Role of Calcium Signaling.
    Li Y; Zhang Z; Li S; Yu T; Jia Z
    Front Pharmacol; 2021; 12():682273. PubMed ID: 34305595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research on natural products from traditional Chinese medicine in the treatment of myocardial ischemia-reperfusion injury.
    Bu W; Zhang Z; Ocansey DKW; Yu Z; Yang X; Liu Z; Wang X; Ke Y
    Am J Transl Res; 2022; 14(3):1952-1968. PubMed ID: 35422902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects.
    Li LC; Kan LD
    J Ethnopharmacol; 2017 Feb; 198():45-63. PubMed ID: 28038955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.